Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study Evaluating The Use Of Rft5-Dga To Deplete Alloreactive Cells For Patients With Fanconi Anemia After Haploidentical Stem Cell Transplantation

NCT00586274 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00586274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00586274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study Evaluating The Use Of Rft5-Dga To Deplete Alloreactive Cells For Patients With Fanconi Anemia After Haploidentical Stem Cell Transplantation
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Terminated
Start date
March 31, 2002
Completion date
July 31, 2009
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fanconi anemia